nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—PTK2—uterus—peritoneum cancer	0.00192	0.00192	CbGeAlD
Bosutinib—MAP4K5—decidua—peritoneum cancer	0.00191	0.00191	CbGeAlD
Bosutinib—MAP3K3—decidua—peritoneum cancer	0.00191	0.00191	CbGeAlD
Bosutinib—SLK—endometrium—peritoneum cancer	0.00191	0.00191	CbGeAlD
Bosutinib—PHKG1—lymph node—peritoneum cancer	0.00191	0.00191	CbGeAlD
Bosutinib—CASK—lymph node—peritoneum cancer	0.00191	0.00191	CbGeAlD
Bosutinib—STK24—liver—peritoneum cancer	0.00191	0.00191	CbGeAlD
Bosutinib—MAP4K4—female gonad—peritoneum cancer	0.0019	0.0019	CbGeAlD
Bosutinib—EPHB4—endometrium—peritoneum cancer	0.00189	0.00189	CbGeAlD
Bosutinib—EIF2AK1—lymph node—peritoneum cancer	0.00189	0.00189	CbGeAlD
Bosutinib—BCR—female gonad—peritoneum cancer	0.00188	0.00188	CbGeAlD
Bosutinib—NUAK2—female gonad—peritoneum cancer	0.00188	0.00188	CbGeAlD
Bosutinib—SIK1—lymphoid tissue—peritoneum cancer	0.00188	0.00188	CbGeAlD
Bosutinib—IRAK4—lymphoid tissue—peritoneum cancer	0.00188	0.00188	CbGeAlD
Bosutinib—MAP3K12—female gonad—peritoneum cancer	0.00187	0.00187	CbGeAlD
Bosutinib—EPHA2—endometrium—peritoneum cancer	0.00186	0.00186	CbGeAlD
Bosutinib—FYN—endometrium—peritoneum cancer	0.00185	0.00185	CbGeAlD
Bosutinib—TXK—lymph node—peritoneum cancer	0.00185	0.00185	CbGeAlD
Bosutinib—FER—liver—peritoneum cancer	0.00184	0.00184	CbGeAlD
Bosutinib—ERBB3—lymphoid tissue—peritoneum cancer	0.00184	0.00184	CbGeAlD
Bosutinib—MAP2K2—lymphoid tissue—peritoneum cancer	0.00184	0.00184	CbGeAlD
Bosutinib—LYN—liver—peritoneum cancer	0.00183	0.00183	CbGeAlD
Bosutinib—LCK—uterus—peritoneum cancer	0.00183	0.00183	CbGeAlD
Bosutinib—MAP2K1—female gonad—peritoneum cancer	0.00183	0.00183	CbGeAlD
Bosutinib—STK35—female gonad—peritoneum cancer	0.00183	0.00183	CbGeAlD
Bosutinib—FES—lymph node—peritoneum cancer	0.00183	0.00183	CbGeAlD
Bosutinib—VRK2—lymph node—peritoneum cancer	0.00183	0.00183	CbGeAlD
Bosutinib—AXL—uterus—peritoneum cancer	0.00183	0.00183	CbGeAlD
Bosutinib—MAP3K2—lymphoid tissue—peritoneum cancer	0.00182	0.00182	CbGeAlD
Bosutinib—CSK—female gonad—peritoneum cancer	0.00182	0.00182	CbGeAlD
Bosutinib—MAP4K5—endometrium—peritoneum cancer	0.00181	0.00181	CbGeAlD
Bosutinib—MAP3K3—endometrium—peritoneum cancer	0.00181	0.00181	CbGeAlD
Bosutinib—CSNK1A1—female gonad—peritoneum cancer	0.00181	0.00181	CbGeAlD
Bosutinib—YES1—smooth muscle tissue—peritoneum cancer	0.0018	0.0018	CbGeAlD
Bosutinib—BTK—liver—peritoneum cancer	0.0018	0.0018	CbGeAlD
Bosutinib—HCK—female gonad—peritoneum cancer	0.0018	0.0018	CbGeAlD
Bosutinib—CLK1—female gonad—peritoneum cancer	0.0018	0.0018	CbGeAlD
Bosutinib—SRC—epithelium—peritoneum cancer	0.0018	0.0018	CbGeAlD
Bosutinib—SYK—lymph node—peritoneum cancer	0.00179	0.00179	CbGeAlD
Bosutinib—TNIK—lymph node—peritoneum cancer	0.00179	0.00179	CbGeAlD
Bosutinib—TBK1—lymphoid tissue—peritoneum cancer	0.00179	0.00179	CbGeAlD
Bosutinib—PTK2—lymphoid tissue—peritoneum cancer	0.00179	0.00179	CbGeAlD
Bosutinib—ABL2—female gonad—peritoneum cancer	0.00179	0.00179	CbGeAlD
Bosutinib—CDK2—lymph node—peritoneum cancer	0.00178	0.00178	CbGeAlD
Bosutinib—TNK2—liver—peritoneum cancer	0.00177	0.00177	CbGeAlD
Bosutinib—CAMK2G—female gonad—peritoneum cancer	0.00176	0.00176	CbGeAlD
Bosutinib—BMP2K—female gonad—peritoneum cancer	0.00176	0.00176	CbGeAlD
Bosutinib—YES1—decidua—peritoneum cancer	0.00176	0.00176	CbGeAlD
Bosutinib—STK26—lymph node—peritoneum cancer	0.00176	0.00176	CbGeAlD
Bosutinib—SLK—uterus—peritoneum cancer	0.00176	0.00176	CbGeAlD
Bosutinib—LRRK2—female gonad—peritoneum cancer	0.00175	0.00175	CbGeAlD
Bosutinib—MAP4K2—liver—peritoneum cancer	0.00175	0.00175	CbGeAlD
Bosutinib—STK10—decidua—peritoneum cancer	0.00175	0.00175	CbGeAlD
Bosutinib—EPHB4—uterus—peritoneum cancer	0.00174	0.00174	CbGeAlD
Bosutinib—EGFR—female gonad—peritoneum cancer	0.00174	0.00174	CbGeAlD
Bosutinib—TAOK3—decidua—peritoneum cancer	0.00174	0.00174	CbGeAlD
Bosutinib—SRC—smooth muscle tissue—peritoneum cancer	0.00173	0.00173	CbGeAlD
Bosutinib—STK3—liver—peritoneum cancer	0.00172	0.00172	CbGeAlD
Bosutinib—RPS6KB1—lymphoid tissue—peritoneum cancer	0.00172	0.00172	CbGeAlD
Bosutinib—FYN—uterus—peritoneum cancer	0.00171	0.00171	CbGeAlD
Bosutinib—FGR—lymphoid tissue—peritoneum cancer	0.00171	0.00171	CbGeAlD
Bosutinib—PTK2B—female gonad—peritoneum cancer	0.0017	0.0017	CbGeAlD
Bosutinib—AXL—lymphoid tissue—peritoneum cancer	0.0017	0.0017	CbGeAlD
Bosutinib—ROCK1—liver—peritoneum cancer	0.0017	0.0017	CbGeAlD
Bosutinib—CHEK2—lymph node—peritoneum cancer	0.0017	0.0017	CbGeAlD
Bosutinib—SRC—decidua—peritoneum cancer	0.0017	0.0017	CbGeAlD
Bosutinib—WEE1—lymph node—peritoneum cancer	0.00169	0.00169	CbGeAlD
Bosutinib—DMPK—lymph node—peritoneum cancer	0.00169	0.00169	CbGeAlD
Bosutinib—CSNK1E—female gonad—peritoneum cancer	0.00168	0.00168	CbGeAlD
Bosutinib—YES1—endometrium—peritoneum cancer	0.00167	0.00167	CbGeAlD
Bosutinib—MAP4K5—uterus—peritoneum cancer	0.00167	0.00167	CbGeAlD
Bosutinib—BMPR2—liver—peritoneum cancer	0.00165	0.00165	CbGeAlD
Bosutinib—TAOK3—endometrium—peritoneum cancer	0.00165	0.00165	CbGeAlD
Bosutinib—SIK1—female gonad—peritoneum cancer	0.00165	0.00165	CbGeAlD
Bosutinib—IRAK4—female gonad—peritoneum cancer	0.00165	0.00165	CbGeAlD
Bosutinib—STK36—liver—peritoneum cancer	0.00164	0.00164	CbGeAlD
Bosutinib—EPHA4—female gonad—peritoneum cancer	0.00163	0.00163	CbGeAlD
Bosutinib—MERTK—liver—peritoneum cancer	0.00162	0.00162	CbGeAlD
Bosutinib—ERBB3—female gonad—peritoneum cancer	0.00162	0.00162	CbGeAlD
Bosutinib—ULK3—female gonad—peritoneum cancer	0.00161	0.00161	CbGeAlD
Bosutinib—MAP2K2—female gonad—peritoneum cancer	0.00161	0.00161	CbGeAlD
Bosutinib—STK25—lymph node—peritoneum cancer	0.00161	0.00161	CbGeAlD
Bosutinib—MAP3K2—female gonad—peritoneum cancer	0.0016	0.0016	CbGeAlD
Bosutinib—EPHA3—lymph node—peritoneum cancer	0.0016	0.0016	CbGeAlD
Bosutinib—EPHA2—lymphoid tissue—peritoneum cancer	0.0016	0.0016	CbGeAlD
Bosutinib—FYN—lymphoid tissue—peritoneum cancer	0.00159	0.00159	CbGeAlD
Bosutinib—MAP4K4—liver—peritoneum cancer	0.00159	0.00159	CbGeAlD
Bosutinib—MAP3K7—female gonad—peritoneum cancer	0.00159	0.00159	CbGeAlD
Bosutinib—NUAK2—liver—peritoneum cancer	0.00158	0.00158	CbGeAlD
Bosutinib—BCR—liver—peritoneum cancer	0.00158	0.00158	CbGeAlD
Bosutinib—TBK1—female gonad—peritoneum cancer	0.00157	0.00157	CbGeAlD
Bosutinib—PTK2—female gonad—peritoneum cancer	0.00157	0.00157	CbGeAlD
Bosutinib—MAP3K12—liver—peritoneum cancer	0.00157	0.00157	CbGeAlD
Bosutinib—PLK2—lymph node—peritoneum cancer	0.00156	0.00156	CbGeAlD
Bosutinib—MAP2K5—decidua—peritoneum cancer	0.00156	0.00156	CbGeAlD
Bosutinib—MAP4K5—lymphoid tissue—peritoneum cancer	0.00156	0.00156	CbGeAlD
Bosutinib—SIK3—lymph node—peritoneum cancer	0.00155	0.00155	CbGeAlD
Bosutinib—CSF1R—smooth muscle tissue—peritoneum cancer	0.00155	0.00155	CbGeAlD
Bosutinib—YES1—uterus—peritoneum cancer	0.00154	0.00154	CbGeAlD
Bosutinib—IRAK1—female gonad—peritoneum cancer	0.00154	0.00154	CbGeAlD
Bosutinib—MAP2K1—liver—peritoneum cancer	0.00154	0.00154	CbGeAlD
Bosutinib—STK35—liver—peritoneum cancer	0.00154	0.00154	CbGeAlD
Bosutinib—STK10—uterus—peritoneum cancer	0.00153	0.00153	CbGeAlD
Bosutinib—CSK—liver—peritoneum cancer	0.00153	0.00153	CbGeAlD
Bosutinib—CSF1R—decidua—peritoneum cancer	0.00152	0.00152	CbGeAlD
Bosutinib—TAOK3—uterus—peritoneum cancer	0.00152	0.00152	CbGeAlD
Bosutinib—CSNK1A1—liver—peritoneum cancer	0.00152	0.00152	CbGeAlD
Bosutinib—RPS6KB1—female gonad—peritoneum cancer	0.00151	0.00151	CbGeAlD
Bosutinib—HCK—liver—peritoneum cancer	0.00151	0.00151	CbGeAlD
Bosutinib—CLK1—liver—peritoneum cancer	0.00151	0.00151	CbGeAlD
Bosutinib—FGR—female gonad—peritoneum cancer	0.0015	0.0015	CbGeAlD
Bosutinib—LCK—female gonad—peritoneum cancer	0.0015	0.0015	CbGeAlD
Bosutinib—ABL2—liver—peritoneum cancer	0.0015	0.0015	CbGeAlD
Bosutinib—STK4—lymph node—peritoneum cancer	0.0015	0.0015	CbGeAlD
Bosutinib—AXL—female gonad—peritoneum cancer	0.00149	0.00149	CbGeAlD
Bosutinib—MAP2K5—endometrium—peritoneum cancer	0.00148	0.00148	CbGeAlD
Bosutinib—CAMK2G—liver—peritoneum cancer	0.00148	0.00148	CbGeAlD
Bosutinib—BMP2K—liver—peritoneum cancer	0.00148	0.00148	CbGeAlD
Bosutinib—CAMK1D—lymph node—peritoneum cancer	0.00148	0.00148	CbGeAlD
Bosutinib—LRRK2—liver—peritoneum cancer	0.00147	0.00147	CbGeAlD
Bosutinib—STK24—lymph node—peritoneum cancer	0.00146	0.00146	CbGeAlD
Bosutinib—EGFR—liver—peritoneum cancer	0.00146	0.00146	CbGeAlD
Bosutinib—CSF1R—endometrium—peritoneum cancer	0.00145	0.00145	CbGeAlD
Bosutinib—SLK—female gonad—peritoneum cancer	0.00144	0.00144	CbGeAlD
Bosutinib—YES1—lymphoid tissue—peritoneum cancer	0.00144	0.00144	CbGeAlD
Bosutinib—PDGFRB—epithelium—peritoneum cancer	0.00143	0.00143	CbGeAlD
Bosutinib—PTK2B—liver—peritoneum cancer	0.00143	0.00143	CbGeAlD
Bosutinib—EPHB4—female gonad—peritoneum cancer	0.00143	0.00143	CbGeAlD
Bosutinib—STK10—lymphoid tissue—peritoneum cancer	0.00142	0.00142	CbGeAlD
Bosutinib—TAOK3—lymphoid tissue—peritoneum cancer	0.00142	0.00142	CbGeAlD
Bosutinib—FER—lymph node—peritoneum cancer	0.00141	0.00141	CbGeAlD
Bosutinib—ALK—lymph node—peritoneum cancer	0.00141	0.00141	CbGeAlD
Bosutinib—CSNK1E—liver—peritoneum cancer	0.0014	0.0014	CbGeAlD
Bosutinib—EPHA2—female gonad—peritoneum cancer	0.0014	0.0014	CbGeAlD
Bosutinib—FYN—female gonad—peritoneum cancer	0.0014	0.0014	CbGeAlD
Bosutinib—MAP4K1—lymph node—peritoneum cancer	0.00139	0.00139	CbGeAlD
Bosutinib—SIK1—liver—peritoneum cancer	0.00138	0.00138	CbGeAlD
Bosutinib—IRAK4—liver—peritoneum cancer	0.00138	0.00138	CbGeAlD
Bosutinib—SRC—lymphoid tissue—peritoneum cancer	0.00138	0.00138	CbGeAlD
Bosutinib—BTK—lymph node—peritoneum cancer	0.00138	0.00138	CbGeAlD
Bosutinib—PDGFRB—smooth muscle tissue—peritoneum cancer	0.00138	0.00138	CbGeAlD
Bosutinib—MAP3K3—female gonad—peritoneum cancer	0.00137	0.00137	CbGeAlD
Bosutinib—MAP4K5—female gonad—peritoneum cancer	0.00137	0.00137	CbGeAlD
Bosutinib—TNK2—lymph node—peritoneum cancer	0.00136	0.00136	CbGeAlD
Bosutinib—ERBB3—liver—peritoneum cancer	0.00136	0.00136	CbGeAlD
Bosutinib—MAP2K2—liver—peritoneum cancer	0.00135	0.00135	CbGeAlD
Bosutinib—ULK3—liver—peritoneum cancer	0.00135	0.00135	CbGeAlD
Bosutinib—PDGFRB—decidua—peritoneum cancer	0.00135	0.00135	CbGeAlD
Bosutinib—MAP3K2—liver—peritoneum cancer	0.00134	0.00134	CbGeAlD
Bosutinib—MAP4K2—lymph node—peritoneum cancer	0.00134	0.00134	CbGeAlD
Bosutinib—CSF1R—uterus—peritoneum cancer	0.00133	0.00133	CbGeAlD
Bosutinib—MAP3K7—liver—peritoneum cancer	0.00133	0.00133	CbGeAlD
Bosutinib—STK3—lymph node—peritoneum cancer	0.00132	0.00132	CbGeAlD
Bosutinib—TBK1—liver—peritoneum cancer	0.00131	0.00131	CbGeAlD
Bosutinib—PTK2—liver—peritoneum cancer	0.00131	0.00131	CbGeAlD
Bosutinib—IRAK1—liver—peritoneum cancer	0.00129	0.00129	CbGeAlD
Bosutinib—PDGFRB—endometrium—peritoneum cancer	0.00128	0.00128	CbGeAlD
Bosutinib—BMPR2—lymph node—peritoneum cancer	0.00127	0.00127	CbGeAlD
Bosutinib—RPS6KB1—liver—peritoneum cancer	0.00126	0.00126	CbGeAlD
Bosutinib—YES1—female gonad—peritoneum cancer	0.00126	0.00126	CbGeAlD
Bosutinib—LCK—liver—peritoneum cancer	0.00126	0.00126	CbGeAlD
Bosutinib—FGR—liver—peritoneum cancer	0.00126	0.00126	CbGeAlD
Bosutinib—EPHB3—lymph node—peritoneum cancer	0.00126	0.00126	CbGeAlD
Bosutinib—STK36—lymph node—peritoneum cancer	0.00126	0.00126	CbGeAlD
Bosutinib—AXL—liver—peritoneum cancer	0.00125	0.00125	CbGeAlD
Bosutinib—STK10—female gonad—peritoneum cancer	0.00125	0.00125	CbGeAlD
Bosutinib—TAOK3—female gonad—peritoneum cancer	0.00125	0.00125	CbGeAlD
Bosutinib—MERTK—lymph node—peritoneum cancer	0.00124	0.00124	CbGeAlD
Bosutinib—CSF1R—lymphoid tissue—peritoneum cancer	0.00124	0.00124	CbGeAlD
Bosutinib—ABL1—smooth muscle tissue—peritoneum cancer	0.00123	0.00123	CbGeAlD
Bosutinib—MAP4K4—lymph node—peritoneum cancer	0.00122	0.00122	CbGeAlD
Bosutinib—SRC—female gonad—peritoneum cancer	0.00121	0.00121	CbGeAlD
Bosutinib—BCR—lymph node—peritoneum cancer	0.00121	0.00121	CbGeAlD
Bosutinib—NUAK2—lymph node—peritoneum cancer	0.00121	0.00121	CbGeAlD
Bosutinib—SLK—liver—peritoneum cancer	0.00121	0.00121	CbGeAlD
Bosutinib—ABL1—decidua—peritoneum cancer	0.0012	0.0012	CbGeAlD
Bosutinib—MAP3K12—lymph node—peritoneum cancer	0.0012	0.0012	CbGeAlD
Bosutinib—EPHB4—liver—peritoneum cancer	0.0012	0.0012	CbGeAlD
Bosutinib—PDGFRB—uterus—peritoneum cancer	0.00118	0.00118	CbGeAlD
Bosutinib—MAP2K1—lymph node—peritoneum cancer	0.00118	0.00118	CbGeAlD
Bosutinib—STK35—lymph node—peritoneum cancer	0.00118	0.00118	CbGeAlD
Bosutinib—EPHA2—liver—peritoneum cancer	0.00117	0.00117	CbGeAlD
Bosutinib—FYN—liver—peritoneum cancer	0.00117	0.00117	CbGeAlD
Bosutinib—CSK—lymph node—peritoneum cancer	0.00117	0.00117	CbGeAlD
Bosutinib—CSNK1A1—lymph node—peritoneum cancer	0.00116	0.00116	CbGeAlD
Bosutinib—HCK—lymph node—peritoneum cancer	0.00115	0.00115	CbGeAlD
Bosutinib—CLK1—lymph node—peritoneum cancer	0.00115	0.00115	CbGeAlD
Bosutinib—ABL2—lymph node—peritoneum cancer	0.00115	0.00115	CbGeAlD
Bosutinib—MAP3K3—liver—peritoneum cancer	0.00115	0.00115	CbGeAlD
Bosutinib—MAP4K5—liver—peritoneum cancer	0.00115	0.00115	CbGeAlD
Bosutinib—ABL1—endometrium—peritoneum cancer	0.00114	0.00114	CbGeAlD
Bosutinib—CAMK2G—lymph node—peritoneum cancer	0.00113	0.00113	CbGeAlD
Bosutinib—BMP2K—lymph node—peritoneum cancer	0.00113	0.00113	CbGeAlD
Bosutinib—LRRK2—lymph node—peritoneum cancer	0.00112	0.00112	CbGeAlD
Bosutinib—EGFR—lymph node—peritoneum cancer	0.00112	0.00112	CbGeAlD
Bosutinib—MAP2K5—female gonad—peritoneum cancer	0.00112	0.00112	CbGeAlD
Bosutinib—PDGFRB—lymphoid tissue—peritoneum cancer	0.0011	0.0011	CbGeAlD
Bosutinib—PTK2B—lymph node—peritoneum cancer	0.00109	0.00109	CbGeAlD
Bosutinib—CSF1R—female gonad—peritoneum cancer	0.00109	0.00109	CbGeAlD
Bosutinib—CSNK1E—lymph node—peritoneum cancer	0.00108	0.00108	CbGeAlD
Bosutinib—SIK1—lymph node—peritoneum cancer	0.00106	0.00106	CbGeAlD
Bosutinib—IRAK4—lymph node—peritoneum cancer	0.00106	0.00106	CbGeAlD
Bosutinib—YES1—liver—peritoneum cancer	0.00106	0.00106	CbGeAlD
Bosutinib—ABL1—uterus—peritoneum cancer	0.00105	0.00105	CbGeAlD
Bosutinib—EPHA4—lymph node—peritoneum cancer	0.00105	0.00105	CbGeAlD
Bosutinib—STK10—liver—peritoneum cancer	0.00105	0.00105	CbGeAlD
Bosutinib—TAOK3—liver—peritoneum cancer	0.00104	0.00104	CbGeAlD
Bosutinib—ERBB3—lymph node—peritoneum cancer	0.00104	0.00104	CbGeAlD
Bosutinib—MAP2K2—lymph node—peritoneum cancer	0.00104	0.00104	CbGeAlD
Bosutinib—ULK3—lymph node—peritoneum cancer	0.00104	0.00104	CbGeAlD
Bosutinib—MAP3K2—lymph node—peritoneum cancer	0.00103	0.00103	CbGeAlD
Bosutinib—MAP3K7—lymph node—peritoneum cancer	0.00102	0.00102	CbGeAlD
Bosutinib—SRC—liver—peritoneum cancer	0.00102	0.00102	CbGeAlD
Bosutinib—PTK2—lymph node—peritoneum cancer	0.00101	0.00101	CbGeAlD
Bosutinib—TBK1—lymph node—peritoneum cancer	0.00101	0.00101	CbGeAlD
Bosutinib—IRAK1—lymph node—peritoneum cancer	0.000988	0.000988	CbGeAlD
Bosutinib—ABL1—lymphoid tissue—peritoneum cancer	0.000981	0.000981	CbGeAlD
Bosutinib—RPS6KB1—lymph node—peritoneum cancer	0.00097	0.00097	CbGeAlD
Bosutinib—PDGFRB—female gonad—peritoneum cancer	0.000966	0.000966	CbGeAlD
Bosutinib—LCK—lymph node—peritoneum cancer	0.000964	0.000964	CbGeAlD
Bosutinib—FGR—lymph node—peritoneum cancer	0.000964	0.000964	CbGeAlD
Bosutinib—AXL—lymph node—peritoneum cancer	0.00096	0.00096	CbGeAlD
Bosutinib—MAP2K5—liver—peritoneum cancer	0.000936	0.000936	CbGeAlD
Bosutinib—SLK—lymph node—peritoneum cancer	0.000924	0.000924	CbGeAlD
Bosutinib—EPHB4—lymph node—peritoneum cancer	0.000917	0.000917	CbGeAlD
Bosutinib—CSF1R—liver—peritoneum cancer	0.000913	0.000913	CbGeAlD
Bosutinib—EPHA2—lymph node—peritoneum cancer	0.0009	0.0009	CbGeAlD
Bosutinib—FYN—lymph node—peritoneum cancer	0.000899	0.000899	CbGeAlD
Bosutinib—MAP3K3—lymph node—peritoneum cancer	0.000878	0.000878	CbGeAlD
Bosutinib—MAP4K5—lymph node—peritoneum cancer	0.000878	0.000878	CbGeAlD
Bosutinib—ABL1—female gonad—peritoneum cancer	0.000861	0.000861	CbGeAlD
Bosutinib—YES1—lymph node—peritoneum cancer	0.000811	0.000811	CbGeAlD
Bosutinib—PDGFRB—liver—peritoneum cancer	0.00081	0.00081	CbGeAlD
Bosutinib—STK10—lymph node—peritoneum cancer	0.000804	0.000804	CbGeAlD
Bosutinib—TAOK3—lymph node—peritoneum cancer	0.000801	0.000801	CbGeAlD
Bosutinib—SRC—lymph node—peritoneum cancer	0.00078	0.00078	CbGeAlD
Bosutinib—ABL1—liver—peritoneum cancer	0.000722	0.000722	CbGeAlD
Bosutinib—MAP2K5—lymph node—peritoneum cancer	0.000718	0.000718	CbGeAlD
Bosutinib—CSF1R—lymph node—peritoneum cancer	0.0007	0.0007	CbGeAlD
Bosutinib—PDGFRB—lymph node—peritoneum cancer	0.000621	0.000621	CbGeAlD
Bosutinib—ABL1—lymph node—peritoneum cancer	0.000554	0.000554	CbGeAlD
Bosutinib—ABCB1—epithelium—peritoneum cancer	0.000396	0.000396	CbGeAlD
Bosutinib—ABCB1—decidua—peritoneum cancer	0.000374	0.000374	CbGeAlD
Bosutinib—ABCB1—endometrium—peritoneum cancer	0.000355	0.000355	CbGeAlD
Bosutinib—ABCB1—uterus—peritoneum cancer	0.000327	0.000327	CbGeAlD
Bosutinib—CYP3A4—liver—peritoneum cancer	0.000317	0.000317	CbGeAlD
Bosutinib—ABCB1—lymphoid tissue—peritoneum cancer	0.000305	0.000305	CbGeAlD
Bosutinib—ABCB1—female gonad—peritoneum cancer	0.000268	0.000268	CbGeAlD
Bosutinib—ABCB1—liver—peritoneum cancer	0.000225	0.000225	CbGeAlD
Bosutinib—ABCB1—lymph node—peritoneum cancer	0.000172	0.000172	CbGeAlD
